NCT06471673 2024-08-26
A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer
BriaCell Therapeutics Corporation
Phase 1/2 Recruiting
BriaCell Therapeutics Corporation
Second Affiliated Hospital of Guangzhou Medical University